There are various treatment options for uterine fibroids, however, despite their high prevalence and significant impact on patient quality of life, little data exists to formulate evidence-based management guidelines. Uterine fibroid treatment can include a variety of medical and surgical interventions. Treatment strategies should be individualized to each patient based on the location and size of fibroids, severity of symptoms, age, desire for future fertility, and proximity to menopause. It is imperative that clinicians have a strong understanding of all treatment options to best partner with their patients on the creation of personalized management plans.
In the third activity of this CME Outfitters Snack series, expert faculty will provide an overview of the various treatment options for uterine fibroids and help learners to integrate clinical management guidelines for this condition into clinical practice.
Integrate clinical management guidelines for uterine fibroids into practice.
Supported by an educational grant from Pfizer Inc. and Sumitomo Pharma America.
Obstetrician-gynecologists, primary care physicians, nurse practitioners (NPs), physician associates (PAs), and nurses.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Dr. Al-Hendy reports the following financial relationships:
Consultant: AbbVie Inc.; Bayer; Myovant Sciences; Norvartis Pharmaceuticals Corporation; ObsEva; and Pfizer Inc.
Research Support: CrilaHealth
Dr. Lukes reports the following financial relationships:
Research Support: Principal Investigator with funding from: AbbVie Inc.; Bayer; Myovant Sciences; National Institutes of Health (NIH); and Organon
Speakers Bureau: Myovant Sciences
Disclosures were obtained from the CME Outfitters, LLC staff; no disclosures to report:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Call us at 877.CME.PROS (877.263.7767).